{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:35:06Z","timestamp":1791282906102,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Low-level viremia (LLV) is as an early warning signal for treatment failure and onward transmission risk. Uganda has achieved major progress in expanding viral load (VL) testing coverage, yet the burden and trends of LLV among children and adolescents living with HIV (CALHIV) remain insufficiently described. This study assessed national LLV prevalence, temporal trends, and regional distribution from 2014\u20132023 to guide pediatric HIV program planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed routine VL data from Uganda\u2019s Laboratory Information Management System (LIMS) housed at the Central Public Health Laboratories for CALHIV aged 0\u201319 years with VL results between 2014 and 2023. Viral suppression was defined as &lt;200 copies\/mL for plasma and &lt;400 copies\/mL for dried blood spot (DBS) samples. LLV was categorized as 201\u2013999 copies\/mL for plasma and 401\u2013999 copies\/mL for DBS. We analyzed LLV proportions over time and disaggregated them by demographic (age, sex), clinical (ART regimen, duration on ART, adherence, WHO stage), and facility-level (ownership, level of care) characteristics. The Mann-Kendall trend test was used to assess the significance of observed trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 974,873 VL tests were analyzed, of which LLV accounted for 14% (138,126). Nationally, LLV increased from 10.5% in 2014 to 16.2% in 2023 (p\u2009&lt;\u20090.001). LLV rose in both males (10.7% to16.9%, p\u2009&lt;\u20090.001) and females (10.3% to15.6%, p\u2009=\u20090.025), with the steepest increase among infants (12.7%to 22.5%, p\u2009&lt;\u20090.001). Increases were observed among CALHIV on first-line regimens (10.2% to15.7%, p\u2009&lt;\u20090.01), those on ART\u2009\u2265\u20095 years (12.5% to17.8%, p\u2009&lt;\u20090.01), and those with good adherence (10.2% to14.9%, p\u2009&lt;\u20090.001). In 2023, five of fifteen regions recorded LLV prevalence above 20%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The rising LLV burden among CALHIV in Uganda signals emerging virologic challenges that may compromise long-term treatment outcomes. Strengthening VL monitoring, early detection of LLV, and tailored adherence interventions are critical to sustaining viral suppression and preventing progression to high-level viremia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339549","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:33:11Z","timestamp":1781803991000},"page":"e0339549","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends and spatial distribution of low-level viremia among Ugandan children and adolescents, 2014\u20132023"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5137-1139","authenticated-orcid":true,"given":"Janet Kobusinge","family":"Lubega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Twesigye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-9521","authenticated-orcid":true,"given":"Richard","family":"Migisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Bulage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benon","family":"Kwesiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proscovia","family":"Nambuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Sewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor Namusoke","family":"Magongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Riolexus","family":"Ario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"pone.0339549.ref001","author":"UNAIDS"},{"key":"pone.0339549.ref002","author":"UNAIDS","year":"2019"},{"issue":"7","key":"pone.0339549.ref003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1473-3099(13)70363-3","article-title":"Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges","volume":"14","author":"ED Lowenthal","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0339549.ref004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12981-021-00408-1","article-title":"Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda","volume":"18","author":"J Maena","year":"2021","journal-title":"AIDS Res Ther"},{"issue":"6","key":"pone.0339549.ref005","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1097\/MS9.0000000000003272","article-title":"Impact of low-level viremia on HIV non-viral load suppression in low and middle-income countries","volume":"87","author":"JV Mbishi","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"pone.0339549.ref006","volume-title":"Adolescent HIV treatment","author":"UNICEF","year":"2025"},{"key":"pone.0339549.ref007","volume-title":"The role of HIV viral suppression in improving individual health and reducing transmission: policy brief","author":"WHO","year":"2023"},{"key":"pone.0339549.ref008","volume-title":"Uganda population-based HIV impact assessment (UPHIA) 2020\u20132021: final report","author":"MoH","year":"2024"},{"issue":"5","key":"pone.0339549.ref009","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26474","article-title":"Low-level viraemia as a risk factor for virologic failure in children and adolescents living with HIV on antiretroviral therapy in Tanzania: a multicentre, retrospective cohort study","volume":"28","author":"KP McKenzie","year":"2025","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"pone.0339549.ref010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1473-3099(17)30681-3","article-title":"Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study","volume":"18","author":"LE Hermans","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pone.0339549.ref011","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/COH.0000000000000008","article-title":"The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities","volume":"8","author":"M Doherty","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0339549.ref012","volume-title":"Consolidated guidelines for prevention and treatment of HIV\/AIDS in Uganda","author":"Ministry of Health U","year":"2022"},{"issue":"1","key":"pone.0339549.ref013","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4102\/ajlm.v11i1.1899","article-title":"Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa","volume":"11","author":"N Nanyeenya","year":"2022","journal-title":"Afr J Lab Med"},{"key":"pone.0339549.ref014","volume-title":"National population and housing census 2024 \u2013 preliminary report","author":"Uganda Bureau of Statistics","year":"2024"},{"key":"pone.0339549.ref015","year":"2021"},{"key":"pone.0339549.ref016","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Ministry of Health guidelines","author":"MoH","year":"2014"},{"key":"pone.0339549.ref017","volume-title":"Central Public Health Laboratories (CPHL), Uganda Ministry of Health","author":"MoH","year":"2022"},{"key":"pone.0339549.ref018","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"WHO","year":"2016"},{"key":"pone.0339549.ref019","volume-title":"Consolidated guidelines for prevention and treatment of HIV in Uganda","author":"Ministry of Health U","year":"2021"},{"key":"pone.0339549.ref020","volume-title":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach","author":"World Health Organization","year":"2021"},{"issue":"1","key":"pone.0339549.ref021","doi-asserted-by":"crossref","first-page":"8961372","DOI":"10.1155\/2023\/8961372","article-title":"HIV virologic failure among patients with persistent low\u2010level viremia in Nairobi, Kenya: it is time to review the > 1000 virologic failure threshold","volume":"2023","author":"MM Nzivo","year":"2023","journal-title":"BioMed Research International"},{"issue":"3","key":"pone.0339549.ref022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tmi.12656","article-title":"Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges","volume":"21","author":"RA Ferrand","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"1","key":"pone.0339549.ref023","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12879-020-05742-9","article-title":"The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study","volume":"21","author":"R Haghighat","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"12","key":"pone.0339549.ref024","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/cid\/ciw645","article-title":"Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis","volume":"63","author":"RS Boerma","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"pone.0339549.ref025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/hiv.13568","article-title":"Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda","volume":"25","author":"N Nanyeenya","year":"2024","journal-title":"HIV Med"},{"issue":"1","key":"pone.0339549.ref026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1186\/s12879-024-09930-9","article-title":"Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study","volume":"24","author":"F Musiime-Mwase","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"8","key":"pone.0339549.ref027","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpedi.159.8.764","article-title":"Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus","volume":"159","author":"DA Murphy","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"pone.0339549.ref028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration","volume":"56","author":"M-A Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"pone.0339549.ref029","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1258\/0956462052932548","article-title":"Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy","volume":"16","author":"J Byakika-Tusiime","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"7","key":"pone.0339549.ref030","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10461-011-9942-x","article-title":"Adherence to highly active antiretroviral therapy (HAART): a meta-analysis","volume":"15","author":"C Ortego","year":"2011","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0339549.ref031","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/cid\/ciq167","article-title":"Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring","volume":"52","author":"JH McMahon","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0339549.ref032","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/INF.0b013e31816dd325","article-title":"A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries","volume":"27","author":"RC Vreeman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"pone.0339549.ref033","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/ciw001","article-title":"Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges","volume":"62","author":"T Roberts","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pone.0339549.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078609","article-title":"Uganda\u2019s new national laboratory sample transport system: a successful model for improving access to diagnostic services for Early Infant HIV Diagnosis and other programs","volume":"8","author":"C Kiyaga","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:33:16Z","timestamp":1781803996000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339549"}},"subtitle":[],"editor":[{"given":"Benjamin","family":"Chimukangara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339549","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}